SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-237835
Filing Date
2021-08-05
Accepted
2021-08-05 16:48:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d214148ds3.htm S-3 497268
2 EX-4.9 d214148dex49.htm EX-4.9 326169
3 EX-4.10 d214148dex410.htm EX-4.10 332806
4 EX-5.1 d214148dex51.htm EX-5.1 19886
5 EX-5.2 d214148dex52.htm EX-5.2 32859
6 EX-23.1 d214148dex231.htm EX-23.1 1740
7 GRAPHIC g214148g08d77.jpg GRAPHIC 2935
8 GRAPHIC g214148g11e51.jpg GRAPHIC 41181
9 GRAPHIC g214148mintz.jpg GRAPHIC 3358
10 GRAPHIC g214148mintzheader.jpg GRAPHIC 1898
  Complete submission text file 0001193125-21-237835.txt   1276421
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258497 | Film No.: 211149101
SIC: 2834 Pharmaceutical Preparations